| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 320,0 k € | -46.1% | 593,7 k € | +24.9% | 475,4 k € | +38.1% | 344,1 k € | +124.0% | 153,6 k € | +199.7% | -154,0 k € | -23473.9% | -653,4 € | -37.9% | -473,7 € | +74.7% | -1,9 k € | |
| EBITDA | -1,0 M € | +0.2% | -1,0 M € | -26.2% | -829,0 k € | -19.0% | -696,9 k € | -144.5% | -285,1 k € | -12.0% | -254,5 k € | -24025.5% | -1,1 k € | -8.3% | -974,1 € | +63.3% | -2,7 k € | |
| Operating profit | -2,5 M € | -16.0% | -2,2 M € | -37.7% | -1,6 M € | -32.0% | -1,2 M € | -143.3% | -492,2 k € | -66.2% | -296,0 k € | -27958.9% | -1,1 k € | -8.3% | -974,1 € | +74.6% | -3,8 k € | |
| Profit/loss | -2,5 M € | -15.8% | -2,1 M € | -4.7% | -2,0 M € | -69.1% | -1,2 M € | -148.7% | -483,1 k € | -64.1% | -294,4 k € | -26874.3% | -1,1 k € | -9.0% | -1,0 k € | +74.2% | -3,9 k € | |
| Equity | 2,1 M € | -54.5% | 4,5 M € | -2.8% | 4,6 M € | +13733.0% | 33,6 k € | -97.3% | 1,2 M € | -23.7% | 1,6 M € | +705386.9% | 229,4 € | -82.6% | 1,3 k € | -43.1% | 2,3 k € | |
| Total assets | 5,2 M € | -4.0% | 5,5 M € | +3.8% | 5,3 M € | +22.3% | 4,3 M € | +42.8% | 3,0 M € | +80.5% | 1,7 M € | +727790.4% | 229,4 € | -87.6% | 1,8 k € | -20.4% | 2,3 k € | |
| Cash | 56,6 k € | -81.1% | 299,9 k € | -81.2% | 1,6 M € | -3.3% | 1,6 M € | +59.4% | 1,0 M € | -12.1% | 1,2 M € | +512412.4% | 229,4 € | -87.6% | 1,8 k € | -15.7% | 2,2 k € | |
| Debts | 3,2 M € | +439.7% | 590,5 k € | +63.8% | 360,6 k € | -89.3% | 3,4 M € | +89.7% | 1,8 M € | +3361.8% | 51,4 k € | — | 526,6 € | — | ||||
| Staff | 14,3 | 17,1 | 15,3 | 12,2 | 5,5 | 1,8 | — | — | — | |||||||||
Private limited company · Leuven · incorporated on 31/03/2016 · 14,3 ETP
Private limited company loss-making in the latest fiscal year. Cash position declining (-81.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Perseus Biomics is a Private limited company incorporated in 2016. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Leuven. It employs on average 14,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette